Stock Quality:
Last 7 days
-7.4%
Last 30 days
-9.4%
Last 90 days
19.1%
Trailing 12 Months
-72.8%
CGC RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Historical Charts for Stock Metrics
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2025 | 314.0M | 326.9M | 0 | 0 |
| 2024 | 343.9M | 331.1M | 323.0M | 319.1M |
| 2023 | 388.1M | 358.1M | 339.7M | 332.8M |
| 2022 | 616.9M | 372.9M | 455.6M | 397.6M |
| 2021 | 571.4M | 819.0M | 717.7M | 702.8M |
| 2020 | 627.3M | 643.0M | 0 | 539.6M |
| 2019 | 253.4M | 346.9M | 440.4M | 533.9M |
| 2018 | 77.9M | 121.8M | 165.7M | 209.6M |
| 2017 | 39.9M | 0 | 0 | 0 |
| CEO | Mr. David Eric Klein |
|---|---|
| WEBSITE | canopygrowth.com |
| SECTOR | Healthcare |
| INDUSTRY | Drug Manufacturers Specialty & Generic |
| EMPLOYEES | 1621 |